semaglutide causing thyroid cancer Can Cause Issues? FDA Warnings and Safety Facts Weight Loss GLP-1 Drugs and

Marie Spreckley, a postdoctoral researcher at the University of Cambridge working on obesity treatments, told the Wall Street Journal

GLP-1 Agonists and Neuroprotection: Present and Future Studies Glucagon-like peptide 1 (GLP-1) agonists remain popular as weight-loss medications

The effect of semaglutide on cardiovascular outcomes was consistent across all age-based subgroups

(2025, December 1)

Hydration Every serious adverse event in clinical trials involved dehydration from vomiting or diarrhea

We keep the plan practical with pacing, recovery-aware strategies, and coaching that supports sustainable activity while you build healthier routines